BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35233214)

  • 21. Comparative Effectiveness of Reperfusion Strategies in Patients with ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK) Trial.
    Khraishah H; Alahmad B; Secemsky E; Young MN; ElGuindy A; Siedner MJ; Kassab M; Kholte D; Khanbhai K; Janabi M; Kennedy K; Albaghdadi MS
    Glob Heart; 2020 Oct; 15(1):68. PubMed ID: 33150133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset.
    Desch S; Stiermaier T; de Waha S; Lurz P; Gutberlet M; Sandri M; Mangner N; Boudriot E; Woinke M; Erbs S; Schuler G; Fuernau G; Eitel I; Thiele H
    JACC Cardiovasc Interv; 2016 Jan; 9(2):113-22. PubMed ID: 26793952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upfront thrombus aspiration in primary coronary intervention for patients with ST-segment elevation acute myocardial infarction: report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) trial.
    Ikari Y; Sakurada M; Kozuma K; Kawano S; Katsuki T; Kimura K; Suzuki T; Yamashita T; Takizawa A; Misumi K; Hashimoto H; Isshiki T;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):424-31. PubMed ID: 19463340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary percutaneous coronary intervention without on-site cardiac surgery backup in unselected patients with ST-segment-elevation myocardial infarction: the Rivoli ST-segment elevation myocardial infarction (RISTEMI) registry.
    Tomassini F; Gagnor A; Montali N; Infantino V; Tizzani E; Tizzani P; Lanza GA; Conte MR; Varbella F
    Cardiovasc Revasc Med; 2013; 14(1):9-13. PubMed ID: 23337379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Outcomes of Patients With ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention Analyzed by Age Groups (<75, 75 to 85, and >85 Years); (Results from the Bremen STEMI Registry).
    Fach A; Bünger S; Zabrocki R; Schmucker J; Conradi P; Garstka D; Fiehn E; Hambrecht R; Wienbergen H
    Am J Cardiol; 2015 Dec; 116(12):1802-9. PubMed ID: 26602071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial.
    Cohen M; Gensini GF; Maritz F; Gurfinkel EP; Huber K; Timerman A; Krzeminska-Pakula M; Santopinto J; Hecquet C; Vittori L;
    Circulation; 2003 Oct; 108(16 Suppl 1):III14-21. PubMed ID: 14605015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
    Scholz KH; Maier SKG; Maier LS; Lengenfelder B; Jacobshagen C; Jung J; Fleischmann C; Werner GS; Olbrich HG; Ott R; Mudra H; Seidl K; Schulze PC; Weiss C; Haimerl J; Friede T; Meyer T
    Eur Heart J; 2018 Apr; 39(13):1065-1074. PubMed ID: 29452351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry.
    Zubaid M; Khraishah H; Alahmad B; Rashed W; Ridha M; Alenezi F; Aljarralah M; Al-Marri K; Almutairi M; Althalji K; Alfaddagh A
    Ann Glob Health; 2020 Feb; 86(1):13. PubMed ID: 32064231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
    Iglesias JF; Muller O; Losdat S; Roffi M; Kurz DJ; Weilenmann D; Kaiser C; Heg D; Valgimigli M; Windecker S; Pilgrim T
    Int J Cardiol; 2021 Jul; 334():37-41. PubMed ID: 33887341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Hahn JY; Kim HK; Park J; Hwang D; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim JH; Kim HS; Jeong MH;
    J Am Coll Cardiol; 2018 Feb; 71(8):844-856. PubMed ID: 29471935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment Windows and Clinical Outcomes in Late-Presenting Patients with ST-Segment Elevation Myocardial Infarction.
    Gao M; Qin L; Zhang Z; Chen L; Zheng Y; Tong Q; Liu Q
    Am J Med Sci; 2019 Oct; 358(4):248-255. PubMed ID: 31327461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left circumflex artery-related myocardial infarction: does ST elevation matter? Results from the Euro Heart Survey PCI registry.
    Bauer T; Gitt AK; Hochadel M; Möllmann H; Nef H; Weidinger F; Zahn R; Hamm CW; Marco J; Zeymer U
    Int J Cardiol; 2013 Oct; 168(6):5239-42. PubMed ID: 23998547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction: A Patient Population Study Comparing a Pharmacoinvasive Strategy With a Primary Percutaneous Coronary Intervention Strategy Within a Regional System.
    Rashid MK; Guron N; Bernick J; Wells GA; Blondeau M; Chong AY; Dick A; Froeschl MPV; Glover CA; Hibbert B; Labinaz M; Marquis JF; Osborne C; So DY; Le May MR
    JACC Cardiovasc Interv; 2016 Oct; 9(19):2014-2020. PubMed ID: 27712737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary percutaneous transluminal coronary intervention compared with intravenous thrombolysis in patients with ST segment elevation myocardial infarction.
    Tungsubutra W; Tresukosol D; Krittayaphong R; Panchavinnin P; Phankingtongkhum R; Chotnaiwattarakul C
    J Med Assoc Thai; 2007 Apr; 90(4):672-8. PubMed ID: 17487120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, predictors, and clinical outcomes of early stent thrombosis in acute myocardial infarction patients treated with primary percutaneous coronary angioplasty (insights from the University of Ottawa Heart Institute STEMI registry).
    Singh K; Rashid M; So DY; Glover CA; Froeschl M; Hibbert B; Chong AY; Dick A; Labinaz M; Le May M
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):842-848. PubMed ID: 28733995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of late reperfusion in ST-segment elevation myocardial infarction: a real-world retrospective cohort study.
    Guo Q; Huang J; Shen Y; Tong G; Li H; Meng S
    BMC Cardiovasc Disord; 2020 Apr; 20(1):207. PubMed ID: 32345243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options.
    Boden WE; Eagle K; Granger CB
    J Am Coll Cardiol; 2007 Sep; 50(10):917-29. PubMed ID: 17765117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention.
    Stehli J; Martin C; Brennan A; Dinh DT; Lefkovits J; Zaman S
    J Am Heart Assoc; 2019 May; 8(10):e012161. PubMed ID: 31092091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.